Revance Therapeutics, Inc.

MetLife Investment Management, LLC

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/13/2025

Shares

60,514

Value ($000)

184

Weight

0.0%

2018 Q3 - 2024 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/13/2025	184	0.0%	60,514	12/31/2024
2024 Q3	11/13/2024	292	0.0%	56,279	9/30/2024
2024 Q2	8/13/2024	142	0.0%	55,269	6/30/2024
2024 Q1	5/14/2024	179	0.0%	36,423	3/31/2024
2023 Q4	4/22/2024	387	0.0%	43,980	12/31/2023
2023 Q3	5/9/2024	504	0.0%	43,980	9/30/2023
2023 Q2	4/29/2024	1,113	0.0%	43,980	6/30/2023
2023 Q1	5/9/2024	1,363	0.0%	42,327	3/31/2023
2022 Q4	5/10/2024	781	0.0%	42,327	12/31/2022
2022 Q3	5/10/2024	1,056	0.0%	39,127	9/30/2022
2022 Q2	5/10/2024	541	0.0%	39,127	6/30/2022
2022 Q1	5/10/2024	763	0.0%	39,127	3/31/2022
2021 Q4	5/17/2024	415	0.0%	25,433	12/31/2021
2021 Q3	5/17/2024	709	0.0%	25,433	9/30/2021
2021 Q2	5/17/2024	754	0.0%	25,433	6/30/2021
2021 Q1	5/17/2024	711	0.0%	25,433	3/31/2021
2020 Q4	5/24/2024	721	0.0%	25,433	12/31/2020
2020 Q3	5/24/2024	639	0.0%	25,433	9/30/2020
2020 Q2	5/24/2024	621	0.0%	25,433	6/30/2020
2020 Q1	7/12/2023	316	0.0%	21,348	3/31/2020
2019 Q4	7/12/2023	346	0.0%	21,348	12/31/2019
2019 Q3	7/12/2023	278	0.0%	21,348	9/30/2019
2019 Q2	7/12/2023	277	0.0%	21,348	6/30/2019
2019 Q1	7/13/2023	245	0.0%	15,532	3/31/2019
2018 Q4	7/13/2023	313	0.0%	15,532	12/31/2018
2018 Q3	7/13/2023	386	0.0%	15,532	9/30/2018